Michel Lamure

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma

F. Bernard-Arnoux, Michel Lamure, François Ducray et al. · Neuro-Oncology · 2016 · 105 citations · Full text

Methodological considerations in cost of illness studies on Alzheimer disease

Hélène Derumeaux, Thomas Rapp, Valérie Garnault et al. · Health Economics Review · 2012 · 89 citations · Full text

Concordance Rate Differences of 3 Noninvasive Imaging Techniques to Measure Carotid Stenosis in Clinical Routine Practice

Michel Nonent, Jean‐Michel Serfaty, Norbert Nighoghossian et al. · Stroke · 2004 · 83 citations · Full text

Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project

Ariel Béresniak, Antonieta Medina‐Lara, J. P. Auray et al. · PharmacoEconomics · 2014 · 63 citations

Quality Of Life, Family Medicine, Underlying Assumptions +15

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature

Susana Murteira, Zied Ghezaiel, Slim Karray et al. · Journal of Market Access & Health Policy · 2013 · 60 citations · Full text